Table 1. Patient demographics.

Variables	Surgery +/− adjuvant therapy				Neoadjuvant therapy
	≤800 (n=1,907)	>800 (n=2,223)	P value		≤800 (n=256)	>800 (n=336)	P value
Age	66.0	66.8	0.0174		63.4	64.2	0.326
18–59	27.2%	23.5%			36.7%	31.8%
60–69	32.2%	33.7%			34.5%	36.4%
70–79	31.4%	32.1%			24.2%	25.5%
80–90	9.3%	10.7%			4.5%	6.3%
Sex			0.893				0.409
Male	51.2%	51.4%			47.3%	50.7%
Female	48.8%	48.6%			52.7%	49.3%
Race			0.002				0.007
White (Non-Hispanic)	76.6%	78.7%			75.0%	85.7%
Black (Non-Hispanic)	11.1%	7.8%			14.4%	8.3%
Other (Non-Hispanic)	3.5%	3.2%			3.4%	1.1%
Hispanic	8.8%	10.3%			7.2%	4.9%
Insurance			0.013				0.009
Private	34.8%	34.3%			45.1%	46.4%
Medicare	54.0%	54.7%			41.7%	46.7%
Medicaid & other gov	7.2%	5.7%			9.5%	3.7%
Unknown	1.2%	2.4%			1.9%	0.3%
Not insured	2.8%	2.8%			1.9%	2.9%
Median income			0.093				0.004
<58,000	17.4%	15.0%			17.4%	12.3%
58,000–74,000	23.5%	23.6%			26.1%	19.5%
74,000–93,000	24.2%	26.7%			21.2%	33.2%
>93,000	32.5%	31.0%			32.6%	30.1%
Comorbidities			0.072				0.216
CDCC score 0	67.0%	63.7%			68.2%	62.8%
CDCC score 1	26.3%	28.4%			26.5%	33.0%
CDCC score 2	6.7%	7.9%			5.3%	4.3%
CDCC score missing	0.0%	0.0%			0.0%	0.0%
Facility type			0.412				0.772
Community	4.0%	4.1%			1.9%	1.4%
Comprehensive community	38.9%	40.8%			29.5%	31.8%
Academic/research	56.8%	55.0%			68.6%	66.8%
Other	0.4%	0.2%			0.0%	0.0%
Facility location			0.031				0.333
Northeast	21.6%	18.4%			22.0%	28.4%
South	35.6%	35.1%			34.8%	31.5%
Midwest	27.8%	30.1%			31.8%	28.7%
West	15.0%	16.4%			11.4%	11.5%